Current Studies

Select Study Type: 

SpecialtyProtocolInvestigatorContact
Eye - Growth FactorsExamination of Growth Factors in Eye Musclesvon Bartheld, MDC. von Bartheld, MD 775-784-0622
Interventional Radiology - Intracranial StentNeuroform 3 Intracranial Stent humanitarian use deviceRangaswamy, MDInterventional rad 775-982-4492
Cancer - PET scanNational Oncologic PET Registry (NOPR)Kenton, MDChristine 775-982-6672
Cardiology - stentJostent Coronary Covered Stent GraftIchino, MDRebecca - 775-982-5154
Cancer - Advanced Endometrial CaancerGOG 0258 A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial CancerLim, MDAnna/Shannon 775-982-5050
Cancer - Cervical CancerGOG 0263 Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic LymphadenectomyLim, MDAnna/Shannon 775-982-5050
Interventional Radiology - vascular deviceENTERPRISE Vascular Reconstruction Device and Delivery System Humanitarian Use DeviceRangaswamy, MDRebecca 775-982-5154
Diabetes - Genetic ScreeningTrialNet Natural History Study of the Development of Type I diabetes Phase 1: ScreeningEckert, MDDr. Eckert 775.333.8000
OB - RNA Preterm Labor BiopsyNew Therapeutic Targets for Treatment of Preterm LaborBuxton, PhDSara 775-784-4120
Interventional Radiology - StentWingspan Stent System with Gateway PTA Balloon Catheter--Humanitarian Use DeviceRangaswamy, MDRebecca 775-985-5154
Surgery - Motility Human ColonControl of Motility in the Human ColonKeef, PhDKeef - 775-784-4302
Cancer - Breast CancerNSABP B-43 A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by LumpectomyMocherlaAnna/Shannon 775-982-5050
Cancer - Head and NeckECOG E1305 A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck CancerPark, MDAnna/Shannon 775-982-5050
Cancer - Ovarian & Fallopian TubeGOG 0213 A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab (NSC # 704865, IND # 7921) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865, IND #7921) NCI Version 02/23/2010Lim, MDAnna/Shannon 775-982-5050
Cancer - Non-Squamous NSCLCECOG E5508 Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetresed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLCPark, MDAnna/Shannon 775-982-5050
Cell Biology - FibroblastGrowth of Human Foreskin Fibroblast CellsPari, PhDG. Pari - 775-784-4824
Biomedical - AVE0010 recruitmentPotential Patient Recruitment for Lixisinatide/AVE0010Kulick, MDD. Kulick 775-784-1230
Cardiac - AtherosclerosisAtherosclerosis in humans (tissue collection)Miura, MD, PhDH. Miura 775-784-6903
Neurology - Human CognitionNeuropsychological Investigations of Human CognitionBerryhill, PhDM. Berryhill - 775-682-8692
Cancer - Cranial radiation SCLCRTOG 0937 Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)Hardacre, MDAnna/Shannon 775-982-5050
Cancer - Esophageal AdenocarcinomaRTOG 1010 A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal AdenocarcinomaHardacre, MDAnna/Shannon 775-982-5050
Cancer - Limited Small Cell Lung CancerCALGB 30610/RTOG 0538 Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and EtoposideHardacre, MDAnna/Shannon 775-982-5050
Cancer - HER-2 negative BreastSWOG S1007 A phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer With Recurrence Score (RS) of 25 or LessMocherla, MDAnna/Shannon 775-982-5050
Intervential Radiology - Intracranial AneurysmsOnyx HD500 Onyx Liquid Embolis system for the treatment of Intracranial AneurysmsRangaswamy, MDBecky 775-982-5154
Cancer - RenalSWOG S0931 EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III StudyPark, MDAnna/Shannon 775-982-5050
Trauma - Vehicular injuriesAnalysis of Vehicular Injuries and Hospital Costs (Retrospective Analysis)Gomez, MDSnow - 775-982-4344
Education - Epidural Anesthesia Hispanic Pop.A Single Blind, Controlled Study of the Effect of Epidural Anesthesia Educational Materials in Pregnant Hispanic WomenScott, MPHD. Hansen 775-221-2501
Cancer - Prostrate RadiotherapyRTOG 0924 Androgen Deprivation Therapy and High Dose radiotherapy with or without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized TrialHardacre, MDAnna/Shannon 775-982-5050
Pharmacy -Hypoalbuminemia & obesityThe impact of hypoalbuminemia and obesity on mortality and length of stay with ertapenem use in the intensive care unitThuyns, PharmDM. Thuyns 775-982-4406
Cancer - HPV Associated OropharynxRTOG 1016 Phase III Trial of Radiotherapy Plus Cetuximab versus Chemoradiotherapy in HPV-Associated Orthopharynx CancerHardacre, MDAnna/Shannon 775-982-5050
Surgery - Myometrial collectionNew Therapeutic Targets for the Treatment of Preterm LaborBuxton, PhDLab 775-784-4120
Cancer - Breast Early Stage CancerRTOG 1005 A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast CancerHardacre, MDAnna/Shannon 775-982-5050
Biospecimen - CollectionCARIS A Protocol for the Discovery and Initial Validation of a Microvesicle-Based Biosignature for Breast Cancer CDRMA-0003-0212Mocherla, MDAnna/Shannon 775-982-5050
Cell Biology - HCVM GlioblastomaHCMV viral gene expression in the Glioblastoma MultiformePari, PhDG. Pari 775-784-4824
Cancer - MelanomaECOG E1609 A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-risk MelanomaReganti, MDAnna/Shannon 775-982-5050
Cancer - Head and NeckRTOG 0920 A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck CancerHardacre, MDAnna/Shannon 775-982-5050
Cardiology - Registry long-term oral anti-thrombicGLORIA-AF: Global Registry on Long-Term Oral Anti-thrombic Treatment in Patients with Atrial Fibrillation (Phases II/III)Davee, MDJuliana - 775-982-2211
Cancer -Locally Advanced Rectal Resection/ExcisionNCCTG N1048 A Phase II/III trial of Neoadjuvant FOLFOX, with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal ExcisionKennedy, MDAnna/Shannon 775-982-5050
Cancer - Retrospective CT evaluationRetrospective Review of Lumpectomy Bed Boost Techniques with Radiation TherapyWeed, MDD. Weed - 982-4000
Tissue - neuromuscularRoles of microRNAs in Gut Neuromuscular Disorders (tissue collection)Ro, PhDS. Ro 775-784-1462
Surgery - Pre-surgical weight loss dietPre-Surgical Weight Loss Using Protein Meal Replacement Shakes is Associated with Durable Surgical Weight Loss Results at 3 YearsGanser, MDD. Lim - 775-323-7500
Nursing - Diabetes Comp. SurveyNurses' Perceptions of Diabetes: A Comparative AnalysisHagerstrom, PhDJ. Hobson 916-521-9563
Pharmacy - Retrospective Culture FUPharmacist to follow up on cultures in the emergency departmentTownsend, PharmDH Townsend 775-982-2067
Cancer - Recurrent or persistent ovarian etc.GOG 3003 A Ranbdomized, Double-Blind, Plecebo-Controlled Phase II Study of VTX-2337 (IND#78,416) in Combination with Pegylated Liposomal Doxorubicin (PLD) in Patients with Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal CancerLim, MDAnna/Shannon 775-982-5050
Nursing DissertationRN: Decision-Making: Selection of Insulin Injection Sites in Hospitalized PatientsKerr, PhD, RNN Kerr 309-556-3347
OrthopedicsClinical and Economic Impact of Generic Proximal Humerus Locking Plate Utilization at a Level II Trauma CenterAlthausen, MDROC 303-7715
OrthopedicsClinical and Economic Impact of Generic Locking Distal Radius Plate Utilization at a Level II Trauma CenterAltausen, MDROC 303-7715
OrthopedicsClinical and Economic Impact of Generic Clavice Plate Utilization at a Level II Trauma CenterAlthausen, M.D.ROC 303-7715
Ortho/TraumaClinical and Economic Impact of Generic Pedicle Screw and Cage Utilization at a Level II Trauma CenterAlthausen, MDROC 775-303-7715
Internal MedicineImplementation of Sepsis bundle and effect on mortality in patients admitted with sever sepsis in intensive care unitsSiddiqui, MD327-5178
GIGI-001: Intestinal Microbiota TransplantationGray, MDJ. Gray MD 775-852-4848
GIGI-0002: Patient Colon Cancer Screening (Choice of FIT or Colonoscopy Strategy)Gray, MDBrigitte Africa/Shannon White
GIAnalysis of the mechanisms underlying gastric motor disturbances associated with type II diabetesWard, PhDSean Ward 784-6061
OncologyGOG 0225--Can Diet and Exercise Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?Lim, MDCancer Protocols x5050
OncologySWOG S1216--A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate CancerMocherla, MDBrigitte Africa
PedsCystic Fibrosis Foundation Patient RegistryBudhecha, MDDr.Budhecha x6021
CardiologyDECLARE TIMI-58--Dapagliflozin Effect on Cardiovascular Events: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 DiabetesBloch, MDJ. Kipps x2211
PharmacyThe Incidence of Hemorrhagic Complications Obeserved in Patients Who Require Chronic Anticoagulation Therapy with Dabigatran, Rivaroxaban, or WarfarinMohadjer, PharmDK. Mohadjer x4255
PharmacyEvaluation of the diagnosis and Management of Heparin Induced ThrombocytopeniaZion, PharmDL. Zion x 5334
PharmacyThe Effect of Initial Antibiotic Selection on Mortality in Septic Patients Requiring Intensive CareTownsend, PharmDPharmacy x2043
PharmacyEvaluation of a Pharmacist Managed Vancomycin Dosing ProtocolWoodburn, PharmDK.Ward x6045
PharmacyStandardization of Antibiotic Prescribing for Empiric Therapy for Roseview Medical Intensive Care Unit and Tahoe Cardiac Intensive Care Unit at Renown Regional Medical Center (RRMC)Floyd, PharmDK. Ward x 6045
PharmacyThe Use of a Risk Assessment Tool to Identify Patients with Clostridium difficile Diarrhea that May Benefit from Initial Therapy with Fidaxomicin Versus Conventional TherapyHuynh, PharmDK. Ward x6045
OncologyNSABP B-51--A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRTin Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy who Convert to pathologically Negative Axillary Nodes after Neoadjuvant ChemotherapyHardacre, MDBrigette x5050
Wound CareComplex Wounds--Randomized, prospective study of Negative Pressure Wound Therapy to Matristem Xenograft ApplicationSasse, MDOutPt WC x5003
SurgeryISI-dVHb-01: Multicenter Evaluation of Robotic Hysterectomy OutcomesLim, MDBrigitte Africa (x5050)
Ambulatory CareAcute Inpatient Admission Rates for Ambulatory Care Sensitive Conditions (ACSC)SantoraInara Santora 775-920-6569
OncologyNew Link NLG-0505: A Phase III Study of Chemotherapy with or without Algenoantucel-L (Hyoeracyte-Pancreas) Immunotherapy in Subjects with Boardline Resectable or Locally Advanced Unresectable Pancreatic CancerGalanopoulosCancer Research x5050
Managerial ScienceA Financial Assessment of Market Opportunities for a One-Stop ClinicSantoraInara Santora 775-920-6569
OrthopedaedicsFactors Influencing Orthopedic Trauma Room UtilizationAlthausen, MDROC 775-786-3040
OthropedicsExpedient Surgical Fixation of Hip Fractures While Therapeutically Anticoagulated: Is It Safe?Althausen, MDROC 775-786-3040
OrthopedicsThe Effect of Surgical Approach on Long Term Outcomes of Operative Management of Humeral Shaft FracturesAlthausen, MDROC 775-786-3040
NursingExamination of Transfusion PracticeDe Boor, PhD RNDr. DeBoor 775-682-756
NeurologyAMG, 334, 20120295, A Phase 2, Randomized, Double-blind, Placebo­ controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Chronic Migraine PreventionRothrockToni Curri
CardiologyCardiovascular Inflammation Reduction Trial (CIRT): A randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of cardiovascular events among stable coronary artery disease patients with type 2 diabetes or metabolic syndromeRoongsritongJ. Kipps
OrthopedicsDoes a Mobile-Bearing Total Ankle Replacement Maintain Motion at the Tibial and Polyethylene Component Interface?LundeenLinda Dunaway/ROC
NeurologyA Phase IIIb, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Alteplase in Patient with Mild Stroke--Rapidly Improving Symptonis and Minor Neurologic Deficits (PRISMS)Lopez, MDPeggie Smith/Neurology
NeurologyMulticenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Stand of Care Enoxaparin for the Prevention of Venous Thromboembolism in Acute Medically Ill Patients (Protocol 11-019)Lopez, MDPeggy Smith/Neurology
OncologyRTOG 1306: A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)Hardacre, MDBrigit Africa x5050
OncologyECOG E2212: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Adjuvant Everolimus Following the Resection of Metastatic Pancreatic Neuroendocrine Tumors to the LiverGalanopoulos, MDBrigitte Africa x 5050
GI/GUGI-003--Gastric Electrical Stimulation for the Treatment of Gastroparesis [Medtronic Enterra Therapy System Humanitarian Devise Exemption H990014]Gray, MDShannon White x5050
OncologyGOG 0227--A Phase III Randomized Trial of Gemcitabine (NSC#613327) Plus Docetaxel (NSC # 628503) Followed by Doxorubicin (NCS# 123127) vs. Observation for Uterus-Limited, High Grade Uterine LeiomyosarcomaLim, MDBrigittee x5050
OncologyGOG 0286B--A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Verses Paclitaxel/Carboplatin/Placebo as Initial Therapy For Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial CancerLim, MDBrigitte x5050
OncologyGOG 0283--A Phase II Trial of DCTD-Sponsored Dasatinib (NSC #732517, IND #120636) In Recurrent/Persistent Ovary, Fallopian Tube, Primary Peritoneal, and Endometrial Clear Cell Carcinoma Characterized for the Retention or Loss of BAF250a ExpressionLim, MDBrigitte x5050
OncologyGalaxy-2; Protocol 9090-14: A Randomized, Phase 3 Study of Ganetespib in Combination with Docetaxel Vesus Docetaxel Alone in Patients with Advanced Non-Small-Cell Lung AdenocarcinomaSingh, MDBrigitte x5050
NeurologyA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 with Placebo for the Preventative Treatment of High Frequency Episodic Migraine (Sponsor: Labrys Biologics, Inc.)Rothrock, MDToni Curri x2976
NeurologyA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study Comparing the Efficacy and Safety of Two Doses of Subcutaneous LBR-101 with Placebo for the Preventative Treatment of High Frequency Chronic Migraine (Sponsor: Labrys Biologics, Inc.)Rothrock, MDToni Curri x 2976
EconomicsAnalysis of the Net Impact of Obesity on Employers (after accounting for the impact of obesity on wages)WendelDr. Jeanee Wendel 784-8017
CardiovascularA Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment with BELVIQ (locaserin HCL) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects with Cardiovascular Disease or Multiple Cardiovascular Risk FactorsBloch, MDJ Kipps x2211